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ABSTRACT
Liver ischemia has been considered a frequent problem in medical practice, and can be associated to a number of surgical
and clinical situations, such as massive hepatic resections, sepsis, liver trauma, circulatory shock and liver transplantation.
After restoring blood flow, the liver is further subjected to an additional injury more severe than that induced by ischemia.
On account of the complexity of mechanisms related to pathophysiology of ischemia and reperfusion (I/R) injury, this
review deals with I/R effects on sinusoidal microcirculation, especially when steatosis is present. Alterations in hepatic
microcirculation are pointed as a main factor to explain lower tolerance of fatty liver to ischemia-reperfusion insult. The
employment of therapeutic strategies that interfere directly with vasoactive mediators (nitric oxide and endothelins) acting
on the sinusoidal perfusion seem to be determinant for the protection of the liver parenchyma against I/R. These approaches
could be very suitable to take advantage of marginal specimens as fatty livers, in which the microcirculatory disarrangements
hamper its employment in liver transplantation.
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RESUMO
A isquemia hepática é um problema relativamente freqüente na prática clínica, sobrevindo em situações diversas como
ressecções hepáticas maciças, sepse, trauma hepático extenso, choque circulatório e transplante hepático. Durante a
restauração do fluxo sanguíneo, o fígado é submetido a uma agressão adicional ainda mais intensa que aquela imposta
pela isquemia. Devido à complexidade dos diversos mecanismos envolvidos na fisiopatologia da lesão por isquemia e
reperfusão (I/R) hepática, esta revisão se limitará a discorrer sobre os efeitos da I/R na microcirculação sinusoidal, com
ênfase para as alterações microvasculares que tomam lugar no fígado esteatótico pós-isquêmico. O desarranjo
microcirculatório é apontado como um importante fator para explicar a reduzida tolerância do fígado esteatótico ao insulto
isquêmico. O desenvolvimento de estratégias terapêuticas capazes de interferir diretamente com os mediadores vasoativos
(óxido nítrico e endotelinas) relacionados ao déficit perfusional será determinante para a proteção do parênquima hepático
frente às alterações induzidas pela I/R. Esses recursos seriam de especial interesse para o aproveitamento de fígados
marginais, cuja falência microcirculatória compromete sobremaneira sua utilização para o transplante hepático.
Descritores: Isquemia-Reperfusão. Fígado Esteatótico. Microcirculação.
Introduction
Blood perfusion to previously ischemic tissue induces
severe tissue injury, which is called ischemia-reperfusion
(I/R) injury.1 In the liver, I/R injury can occur in several
clinical settings such as hepatic trauma, resection of large
intrahepatic tumors and liver transplantation1. Deprivation
of oxygen to the liver during ischemia induces severe
lesions but much more important ones are originated during
reperfusion when oxygen entry to the organ is restored. On
this case, an additional liver aggression occurs exacerbating
greatly the previous injury induced by ischemia.2  Both facts
lead to the induction of multiple and close related
inflammatory processes in liver and extrahepatic organs
which define the complex pathophysiology of I/R injury.
This review deals with effects of I/R syndrome on hepatic
microcirculation, with special emphasis in the induced
alterations in steatotic livers.
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Ischemia and reperfusion injury
The I/R injury is characterized by sinusoidal
vasoconstriction, neutrophil accumulation, platelet
aggregation and alterations on the capillary permeability
leading to a progressive inflammatory reaction with important
microcirculatory alterations, which can trigger diffuse cell
death and consequent acute organ failure.1 The progression
of I/R injury depends primarily on the presence of preexisting
parenchymal alterations, such as hepatic steatosis and
fibrosis, as well as the duration of ischemia period.3 When
oxygen supply to hepatocytes becomes insufficient as
result of reduced or absent blood flow, there is inhibition of
the mitochondrial oxidative phosphorilation with the
subsequent reduction in adenosine triphosphate (ATP)
synthesis. Depletion of cellular ATP store induces
alterations in transmembrane ion transport by inhibition of
the ATP-dependent Na+/K+ ATPase, leading to sodium and
chloride influx changes, intracellular sodium accumulation,
secondary alterationsin cellular calcium homeostasis and,
particularly, cell swelling and death.4 It is well known that
ischemic injury of the liver can be categorized into warm (or
normothermic), cold (or hypotermic) injury, and rewarming.
Whereas warm ischemia occurs in numerous surgical and
clinical circumstances, as major hepatectomies, the cold-
storage ischemia happens almost exclusively in liver
transplantation. Rewarming ischemia typically occurs in
liver transplantation during the period of implantation of
the graft.5 Although the basic mechanisms of these injury
categories are similar in all cases, also significant differences
have been observed. Thus, the main site of injury in cold
ischemia are nonparenchymal cells (sinusoidal endothelial,
Kupffer, stellate and biliary epithelial cells), whereas in warm
ischemia are hepatocytes.6 Rewarming ischemia seems also
involve preferentially hepatocytes. In fact, cold ischemia is
associated with reduced oxidative phosphorylation, lower
cellular ATP levels, and increased glycolysis, while warm
ischemia leads to greater mitochondrial dysfunction and
oxidative stress.7 Although the direct ischemic insult
determinates a significant damage to liver cells, the tissue
injury originated during reperfusion is even so more severe.
An excessive acute inflammatory response, which takes
place promptly after blood flow restoring, has been
recognized as key mechanism of liver injury during
reperfusion period.8  Several studies with experimental
models of warm and cold I/R injury have provided evidences
that hepatic microcirculatory perfusion failure, activation
of Kupffer cells, neutrophils, sinusoidal endothelial cells
(SEC), CD4+ T lymphocytes, and subsequent generation
of reactive oxygen species (ROS), cytokines and
chemokines can be identified as most important episodes
in the pathogenesis of this I/R syndrome.8 It is well assumed
that the Kupffer cells, placed in the sinusoidal space,
constitute the greatest fraction of resident macrophages in
the whole body. Their activation has been considered as a
central event in the pathophysiology of the early
reperfusion injury both after warm and cold ischemia.8
Activation of Kupffer cells leads to the generation of ROS
and other inflammatory mediators, such as the cytokines
(TNF-α, interleukin-1) and vasoactive mediators (nitric
oxide, endothelins) as shown in Figure 1. During the first
hours of reperfusion, ROS are generated by Kupffer cells,
which can act directly as cytotoxins for the hepatocytes
and the SEC, contributing to the progress of liver injury.
Other additional sources of ROS are liver mitochondria and
xanthine/xanthine oxidase system.8
Microcirculatory Failure on Ischemia and
Reperfusion Injury
Liver microcirculation comprises a unique system of
capillaries, called sinusoids, which are lined by a particular
fenestrated endothelium with high permeability that allows
maximum contact between hepatocytes and blood.9
Impairment of liver microcirculation is a main event in the
development of hepatic I/R injury.10 It is well established
that the severity of the microcirculatory disorders are closely
correlated with the importance of applied I/R insult.11 The
nature of the microcirculatory dysfunction after cold
ischemia is quite similar that observed after warm ischemia.12
In the early phase of reperfusion (two hours after blood
supply restoration), the breakdown of active transmembrane
ion transport secondary to the ischemia-induced energy
deficiency results in SEC vacuolization and swelling, as
well as sinusoidal lumenal narrowing, being these factors
responsible for the occurring microcirculation disorders
during reperfusion.11 In addition to intracellular edema
formation, it has been evidenced widening of the Disse’s
perisinusoidal space, microvascular accumulation of
neutrophils, intravascular hemoconcentration, decreased
erythrocyte velocity and extravasation of red blood cell
due to loss of endothelial integrity.11 However, alterations
in capillary vasoconstriction secondary to the imbalance
between endothelins and NO levels (see below) seem to be
the major contributing factor to the microcirculatory
derangement during the reperfusion period.13  Active
vasoconstriction induces progressive exclusion of
sinusoids from perfusion, leading to an increase in the local
heterogeneity of blood flow and oxygen supply. Indeed,
this fact contributes to prolonging hypoxic period in entire
liver lobules, exacerbating thus the tissue ischemic
insult.10,11  In addition, microcirculatory disturbances may
also be triggered by activation of the coagulation cascade
and fibrin deposition during reperfusion.14 Although cellular
ischemic damage is known to be most pronounced in the
acinar pericentral zone (zone 3) after reperfusion, the most
prominent sinusoidal perfusion failure was observed in
periportal zone (zone1).11  This is a consequence of at least
two facts: first, the lumenal narrowing due to SEC swelling
primarily results in periportal microcirculatory deficit, since
periportal sinusoids have normally smaller diameters with
higher blood flow resistance when compared with pericentral
sinusoids.15  Second, the major population of the Kupffer
cells (2/3) is located in the zone 1, showing commonly a
larger size than those ones situated in the zone 3.11 Initially,
it was assumed that the accumulation and adhesion of
neutrophils, as well as platelets, in the hepatic sinusoid
could obstruct the lumen, originating disturbances of the
microcirculation named as “no-reflow” phenomenon.16
However, later investigations argued against this
hypothesis. Thus, during in vivo reperfusion, the sinusoidal
neutrophil stasis was frequently evidenced, but these
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stagnant neutrophils did not necessarily occlude the
capillary lumen.17 In addition, the microvascular neutrophil
accumulation had not any effect on sinusoidal perfusion
when an isolated perfused rat liver model was used.18 Recent
investigations have corroborate that the main causative
factor to impairment of postischemic microcirculation is the
increased local synthesis of potent vasoconstrictor
peptides, as endothelins (ETs), which are generated during
earlier stages of reperfusion, being responsible for the
reduction of sinusoidal diameter with the subsequent
induction of microcirculatory derangements.13,19 This was
confirmed by the fact that the intraportal infusion of ET-1
decreased the mean sinusoidal diameter and increased the
heterogeneity of sinusoidal perfusion. Both effects are
mainly produced by contraction of appendages of stellate
cells that wrap around the sinusoids.20  Moreover,
pretreatments with anti-ET-1 antibody or ET receptor
antagonist (bosentan) increased microcirculatory blood
flow, attenuated tissue damage during reperfusion and
improved survival.21,22 ETs are likely released by SEC, Kupffer
and stellate cells in response to hypoxia, reactive oxygen
species, proinflammatory cytokines and bacterial
lipopolysaccharides (LPS).23 Gene expression of ETs
receptor was found greatest on stellate cells, followed by
SEC and Kupffer cells.24 Nitric oxide (NO) is a potent gaseous
vasodilator involved in the regulation of hepatic
microcirculation. Two major isoforms of NO synthase (NOS)
are found in the liver, endothelial “constitutive” NOS
(eNOS, NOS-3) and inducible NOS (iNOS, NOS-2).25
Endothelial NOS is expressed constitutively and exclusively
in the SEC, and releases small amounts of NO for short
periods of time. In contrast, iNOS synthesizes large amounts
of NO for sustained periods, and can be transcriptionally
up-regulated in all liver cells, e.g., hepatocytes, SEC, Kupffer
and stellate cells, usually in response to inflammatory
mediators. NO diffuses freely to adjacent cells and enters
the cytosol, where it activates guanylate cyclase, resulting
in an intracellular increase of cGMP levels.25 It is assumed
that eNOS-derived NO production is protective in liver I/R
injury through the regulation of sinusoidal diameter,
prevention of neutrophil adhesion, inhibition of platelet
aggregation and adhesion, and scavenging of reactive
FIGURE 1 - Pathophysiological mechanisms of liver ischemia-reperfusion injury. Ischemia and reperfusion trigger activation
of Kupffer cells (KC), which can generate reactive oxygen species (ROS) and cytokines TNF-α and IL-1. The
imbalance between endothelins (ET) and nitric oxide (NO) produced by sinusoidal endothelial cells (SEC)
leads to active vasoconstriction, narrowing of sinusoidal lumen and, the subsequent microcirculatory failure.
TNF-α and IL-1 promotes neutrophil (PMN) activation, recruitment and transendothelial migration, which
culminate in neutrophil-induced SEC and hepatocyte injury by releasing of ROS and proteases. Sinusoidal
narrowing also contributes to hepatic neutrophil accumulation.
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oxygen species.26 Moreover, NO derived from eNOS
attenuates sinusoidal perfusion failure improving liver tissue
oxygenation and finally counteracting the transient
vasoconstrictor effects of ETs synthesized during earlier
stages of reperfusion.27 The relevance of NO in hepatic
microcirculation is supported by the fact that administration
of eNOS inhibitors reduced microvascular perfusion and
aggravated I/R injury, while the supplementation with L-
arginine (NO precursor) or NO donors improved
microcirculatory status and minimized liver damage after I/
R.25 Results published in a recent paper using mice
genetically modified deficient in either eNOS or iNOS
suggest that eNOS, but not iNOS, plays an important role
in downregulating I/R injury during early reperfusion
period.28  This is consistent with the fact that iNOS activation
needs more time to be activated by different stimuli as pro-
inflammatory cytokines and LPS.29,30 In any case, the benefits
of iNOS activation in liver I/R seem to be controversial.31-33
Excessive NO production is detrimental because could be
responsible for changes in systemic vascular tone and
reactivity leading to hypotension and circulatory shock. In
addition, the generation of peroxynitrite, a potent oxidant,
formed by reacting NO with  superoxide anion, could also
cause cell injury through lipid peroxidation, direct inhibition
of mitochondrial respiratory chain enzymes, inhibition of
membrane Na+/K+ ATPase activity, or oxidative protein
modification such as formation of nitrotyrosine.2
Hepatic Steatosis and Microcirculatory Failure
Hepatic steatosis or fatty liver is the result of the
abnormal accumulation of triacylglycerol within the
cytoplasm of hepatocytes, with an incidence ranging from
6 to 11% in autopsies of accidental deaths in developed
countries.34 The steatosis could be quantitatively classified
according to the fat infiltration in the hepatocytes as mild
(less than 30% of the hepatocytes have fat vacuoles within
the cytoplasm), moderate (between 30 and 60%) or severe
(more than 60%).35 Histologically, it is classified as macro
and microvesicular steatosis. In macrovesicular steatosis,
the hepatocytes are distended by a single large vacuole,
which displaces the nucleus to one side. This is in general
considered a benign and reversible condition. In the other
hand, microvesicular steatosis is more serious and often
associated with impairment of β-oxidation of lipids and
inflammatory changes. In that case, multiple small droplets
are finely dispersed in the cytoplasm without nuclear
displacement.35 The more frequent causes of macro and
microvesicular steatosis are pointed on the Chart 1. In 1987,
Portman and cols.36 correlated, for the first time, the presence
of steatosis and the primary graft failure. It is well
established that steatosis represents a risk associated with
the viability of the hepatic graft after liver transplantation,
which could justify livers with more than 20% of steatosis
being discarded. However, the lack of organs for
transplantation obligates the utilization of grafts with
moderate steatosis, beside it vulnerability for the I/R injury.37
In despite of the lack of clinic evidences of the mechanisms
through which these two kinds of steatosis affect the I/R
injury, recent investigations demonstrated that mouse
macrosteatotic livers are more susceptible for the I/R injury
than those with microsteatosis.34 It is well known that the
triglycerides deposition as intracytoplasmic fat droplets is
associated with an increase in hepatocellular volume, which
may induce distortion and narrowing of sinusoid, with
reduction of the luminal diameter by up to 50% compared
with that in the normal liver.38 Consequently, increases in
liver fat infiltration are consistent the apparition of severe
CHART 1 - Main causes of macro and microvesicular steatosis.
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alterations in liver blood flow and hepatic microcirculation,
respectively. In this line, it has been suggested that
sinusoidal perfusion alterations in macrovesicular steatosis,
could be associated with a mechanical compression of the
sinusoidal spaces by the steatosis and by the neutrophil
swelling.38 The importance of the control of the balance
between ETs/NO seems to be crucial for the sinusoidal
perfusion regulation and consequently, for subsequent
modulation of hepatic microcirculation disturbances in liver
steatosis.35  Thus, the administration of L-arginine, a NO
precursor, contributes for the microvascular perfusion in
the fatty livers by increasing NO generation, which
compensates the sinusoidal vasoconstriction induced by
ETs, leading, thus, to the amelioration of microcirculatory
disturbance associated with steatosis.34 Also, the importance
of the ETs/NO balance confirmed by the application of
surgical strategies, as ischemic preconditioning (IP),
protects the liver from I/R injury. It is well established that
liver IP stimulates the endogenous production of NO, whose
inhibitory action on the ETs generated during reperfusion
would explain the benefits of IP on the improvement of
sinusoidal perfusion and tissue oxygenation34, respectively.
Similar beneficial effects of NO generation on steatotic liver
microcirculation have been described when steatotic liver
grafts were conserved in IGL-1 solution.  IGL-1 solution
resulted in better preservation of fatty grafts when compared
to the traditional University of Wisconsin solution.39 The
advantages of IGL-1 seem to be associated with increased
NO levels after cold preservation by activation of eNOS.
This could compensate the vasoconstrictor effects of the
ETs produced during cold ischemia, contributing, thus, to
the amelioration of microcirculatory disorders.39 At last, it is
important to remark that is necessary to explore new
therapeutic strategies that interfering directly on ETs/NO
balance for protecting microcirculation alterations induced
in normal and fatty livers I/R injury. These approaches will
be determinant to take advantage of marginal livers, as
steatotic grafts, whose microcirculatory failure compromise
its use for liver transplantation purposes.
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